Un grupo investigador de la URV-IISPV-HUSJR compara las características de los primeros 200 pacientes con SARS-CoV-2 de cada ola, ingresados en el Hospital Universitario Sant Joan de Reus, para enten...
Read more
The National Institutes of Health (NIH-NIAID) in the USA has established a consortium to identify the environmental factors and underlying immune mechanisms that may explain the variation in response ...
Read more
Oryzon Genomics, S.A., announced today the approval by the EU-intergovernmental organization EUREKA secretariat of funding for the BRAVE Project (Breaking immune Resistance of Advanced cancers by HERV...
Read more
ISGlobal leads a 1 million euros EU-funded action grant to increase viral hepatitis testing, vaccination, and linkage to care among migrant and refugee populations in Greece, Italy and Spain
Read more
La aportación de Oryzon se destinará a distribuir la vacuna neumocócica en Mozambique y Etiopía para prevenir la neumonía, la mayor causa de mortalidad infantil por enfermedad infecciosa a escala...
Read more
It has been demonstrated the ability of SARS-CoV-2 to infect different regions of the brain and to cause brain damage, and how the CNB-CSIC vaccine fully protects against infection of the brain. These...
Read more
La inactivación de la β2-microglobulina disminuye las posibilidades de que el virus se interne en la célula y podría ofrecer nuevas dianas para el desarrollo de antivirales
Read more
Han desarrollado una vacuna contra la leishmaniasis canina basada en ADN recombinante. Esta vacuna, la primera en mamíferos animales y la segunda en el mundo con esta tecnología, basada en fragmento...
Read more
Now, a mutation has given rise to the XBB.1.5 or Kraken variant, detected for the first time in October 2022 in the US. This variant is new, but it's still Omicron.
Read more
The vaccines offer high protection against severe COVID-19 symptoms, with an effectiveness of up to 91% in infected women who had received the complete vaccination regimen and a booster dose.
Read more
The results of the first trial, published in the journal Nature Medicine, have shown that the vaccine is safe and provides partial control of the virus in 40% of participants who have received the vac...
Read more
Este estudio demuestra que los menores de 5 años que habían recibido la pauta completa de vacunación frente al meningococo B presentaron un riesgo de padecer enfermedad invasiva por meningococo B u...
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
